Incyclix Bio
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer (NCT05735080) | Incyclix Bio | 2023-03-28 |
Track Incyclix Bio automatically
Every clearance here is in the API, with alerts when new ones post.